tiprankstipranks
Novus Acquisition & Development Corp. (NDEV)
OTHER OTC:NDEV
US Market
Holding NDEV?
Track your performance easily

Novus Acquisition & Development (NDEV) Stock Price & Analysis

74 Followers

NDEV Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

0.02%99.98%
Insiders
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors

NDEV FAQ

What was Novus Acquisition & Development Corp.’s price range in the past 12 months?
Novus Acquisition & Development Corp. lowest stock price was $0.01 and its highest was $0.13 in the past 12 months.
    What is Novus Acquisition & Development Corp.’s market cap?
    Currently, no data Available
    When is Novus Acquisition & Development Corp.’s upcoming earnings report date?
    Novus Acquisition & Development Corp.’s upcoming earnings report date is May 28, 2025 which is in 187 days.
      How were Novus Acquisition & Development Corp.’s earnings last quarter?
      Novus Acquisition & Development Corp. released its earnings results on May 29, 2024. The company reported $0 earnings per share for the quarter, the consensus estimate of N/A by $0.
        Is Novus Acquisition & Development Corp. overvalued?
        According to Wall Street analysts Novus Acquisition & Development Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Novus Acquisition & Development Corp. pay dividends?
          Novus Acquisition & Development Corp. does not currently pay dividends.
          What is Novus Acquisition & Development Corp.’s EPS estimate?
          Novus Acquisition & Development Corp.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Novus Acquisition & Development Corp. have?
          Novus Acquisition & Development Corp. has 97,853,620 shares outstanding.
            What happened to Novus Acquisition & Development Corp.’s price movement after its last earnings report?
            Novus Acquisition & Development Corp. reported an EPS of $0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Novus Acquisition & Development Corp.?
              Currently, no hedge funds are holding shares in NDEV
              ---

              Novus Acquisition & Development Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              335.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              9.36%
              Trailing 12-Months
              Asset Growth
              4.42%
              Trailing 12-Months

              Company Description

              Novus Acquisition & Development Corp.

              Novus Acquisition & Development Corp is a holding company operating through its holdings. It primarily offers health, life, and annuity insurance products and services. The company initiated its health insurance business model within the medical marijuana space where it can render risk and non-risk insurance models in Washington, Oregon, Hawaii, Michigan, Arizona, Colorado, California, Washington, New York, Massachusetts and Vermont.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              SinglePoint
              California Nanotechnologies
              Federal Life Group
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis